Genes, microbes, and T cells--new therapeutic targets in Crohn's disease.
Elson
Charles O
CO
University of Alabama at Birmingham, 35294-0007, USA.
D017209:Apoptosis; D002352:Carrier Proteins; D003424:Crohn Disease / Q000235:genetics* / Q000276:immunology; D020022:Genetic Predisposition to Disease; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D016328:NF-kappa B / Q000378:metabolism; D053473:Nod2 Signaling Adaptor Protein; D011506:Proteins / Q000235:genetics*; D011956:Receptors, Cell Surface / Q000378:metabolism; D015398:Signal Transduction; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D002352:Carrier Proteins; D047908:Intracellular Signaling Peptides and Proteins; D016328:NF-kappa B; C429018:NOD2 protein, human; D053473:Nod2 Signaling Adaptor Protein; D011506:Proteins; D011956:Receptors, Cell Surface; D014409:Tumor Necrosis Factor-alpha